drugset / Trial / NCT03824847

Immunomodulatory Effect of Macrolides in Naturally Occurring Influenza Virus Infections in the Community

NCT03824847

Phase 4 Suspended 100 enrolled The University of Hong Kong
RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators propose a double-blind randomised placebo-controlled study in naturally occurring influenza virus infections in the community setting to compare the impact of a short course of clarithromycin versus placebo, on the clinical course, viral shedding, immunomodulation, and the antimicrobial resistance pattern of respiratory bacterial carriage of the patients.

Timeline

Start
2023-06-01
Primary completion
2024-03-01
Completion
2024-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clarithromycin Small molecule 250 mg Oral

Indications